Aspire Congestion and Cough Relief DM Softgels
- Product NDC
- 81013-104
- 11-digit product format
- 810130104
- Labeler code
- 81013
- Product ID
- 81013-104_dbc517f5-ac4f-6ad3-e053-2a95a90a5aee
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Aspire Congestion and Cough Relief DM Softgels
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Labeler
- Aspire Pharmaceuticals Inc
- Application
- part341
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2022-04-14
- Marketing end
- 0000-00-00
- Substance
- DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
- Active strength
- 10 mg/1; mg/1
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 81013-104-01 | 81013010401 | 8000 CAPSULE, LIQUID FILLED in 1 BAG (81013-104-01) | 2022-04-14 | 0000-00-00 | No | No | Current |